Flash Player 6+ Required for Site Navigation.

 
Flash Player 6+ Required.
 
 
 
 

 

 
 

Carol Walborn, President and CEO of For Patients, Inc., and Inventor of the CathSling.

 

 
 
Click to View Demonstration
 
 

ABOUT US

For Patients, Inc.

 

"I am a cancer survivor who experienced a life-threatening, catheter-related infection due to the poor catheter securement  of tape and pins. I also experienced skin trauma when  adhesive tape was used to support my catheter lines. I designed the CathSling to prevent these problems and now  provide the CathSling through healthcare providers and distributors. With the aid of the CathSling I was better equipped to focus on my treatment. Today I am cancer free."

 

For Patients, Inc. is a North Carolina Corporation established in March of 2004 to develop, test, manufacture, market and distribute innovative medical devices and products.

Our products are manufactured in FDA certified clean rooms and sterilized and packaged according to FDA regulations. We use only U.S.- based suppliers, manufacturers and packaging facilities that provide large volume capacity and the highest quality control based on ISO 9000 standards. We contract only with manufacturers that provide a quick turn-around from ordering to delivery.

For Patients Inc. is the exclusive manufacturer and nationwide distributor of the CathSlingCath Sling Trademark, a patented, non-adhesive catheter securement device that supports the infusion lines of Central Venous Catheters, Portacaths, and PICCS. And now the Animal CathSling is available!

The For Patients, Inc. team consists of physicians, nurses, health care executives, medical marketing professionals, veterinarians, a medical illustrator and a bio-engineer. They serve as members of the Board of Directors, the Advisory Board and/or as members of our professional staff.

 

 
 

 

 

The For Patients Team.

 A Diversified Group of Medical Professionals and Former Patients.

 
 

  For Patients, Inc.

 

Home   |   Patients   |   Providers   |   Distributors   |   About Us   |   News   |   Contact   |   Site Map